154 related articles for article (PubMed ID: 37597686)
1. Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy.
Ma S; Bhar S; Guffey D; Kim RB; Jamil M; Amos CI; Lee SJ; Hingorani SR; Sartain SE; Li A
Transplant Cell Ther; 2023 Nov; 29(11):685.e1-685.e7. PubMed ID: 37597686
[TBL] [Abstract][Full Text] [Related]
2. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
3. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
4. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
Sartain S; Shubert S; Wu MF; Wang T; Martinez C
Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
[TBL] [Abstract][Full Text] [Related]
5. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
6. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J; Hammers YA; Rytting H; Williams KM
Transplant Cell Ther; 2023 Jan; 29(1):45.e1-45.e8. PubMed ID: 36202334
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Schoettler M; Lehmann L; Li A; Ma C; Duncan C
Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
[TBL] [Abstract][Full Text] [Related]
9. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
[TBL] [Abstract][Full Text] [Related]
10. D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B; Stenger E; Qayed M; Chonat S; Westbrook A; Switchenko J; Williams KM
Am J Hematol; 2024 Mar; 99(3):370-379. PubMed ID: 38164997
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.
Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao PC; Ma C; Duncan CN
Blood Adv; 2020 Jun; 4(11):2536-2547. PubMed ID: 32516415
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy.
Schoettler ML; Bhatt H; Vasu S
Front Immunol; 2022; 13():1064203. PubMed ID: 36818475
[TBL] [Abstract][Full Text] [Related]
15. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
17. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors.
Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM
Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214
[TBL] [Abstract][Full Text] [Related]
19. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
[TBL] [Abstract][Full Text] [Related]
20. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
